It's just the FDA's rule set mate. 6 months for a Class 2 review (i.e. anything that's not covered by a Class1 review). As frustrating as it is to us, could you imagine the allegations of favoritism and corruption if the FDA applied different timelines to different reviews purely based on 'common sense'! The FDA are a government bureaucracy - they're not in business to make money!
- Forums
- ASX - By Stock
- BOT
- Ann: NDA Resubmission Accepted and Approval Date Confirmed
Ann: NDA Resubmission Accepted and Approval Date Confirmed, page-109
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.025(7.04%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
36.5¢ | 38.0¢ | 36.0¢ | $3.158M | 8.589M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 141840 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 135173 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 121840 | 0.375 |
4 | 61036 | 0.370 |
6 | 265949 | 0.365 |
14 | 404962 | 0.360 |
14 | 404158 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 135173 | 2 |
0.385 | 76800 | 4 |
0.390 | 567200 | 7 |
0.395 | 451501 | 6 |
0.400 | 910507 | 17 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online